Pathogenesis, prevention and treatment of transplant-associated osteoporosis

Journal of the British Menopause Society

Volumn 7, Issue 1, 2001, Pages 9-14

  Fraser, W D ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonate; Immunosuppressants; Osteoporosis; Transplant; Vitamin D

Indexed keywords

AZATHIOPRINE; CALCIUM; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PAMIDRONIC ACID; RAPAMYCIN; TACROLIMUS; VITAMIN D;

AGING; BONE ATROPHY; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW TRANSPLANTATION; BONE MASS; CALCIUM METABOLISM; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG MEGADOSE; FRACTURE; GRAFT REJECTION; HORMONE METABOLISM; HUMAN; HYPOGONADISM; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LUNG DISEASE; MENOPAUSE; MONOTHERAPY; ORGAN TRANSPLANTATION; OSTEODYSTROPHY; OSTEOLYSIS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; RENAL OSTEODYSTROPHY; REVIEW; SEX DIFFERENCE; TREATMENT OUTCOME; VITAMIN D METABOLISM;

EID: 0035087533     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218001100321065     Document Type: Review

References (64)

1. Increased risk of fracture in patients receiving solid organ transplants
2. Bone disease in liver transplant recipients: Incidence, timing and risk factors
3. Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol
4. Bone disease after orthotopic liver transplantation
5. Intravenous biphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
6. Bone loss after liver transplantation
7. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
8. Osteoporosis and skeletal fractures in chronic liver disease
9. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation
10. Osteoporosis in patients undergoing lung transplantation
11. Severe osteoporosis before and after lung transplantation
12. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease
13. Bone loss and fracture after lung transplantation
14. Osteoporosis and lung transplantation: A prospective study
15. High turnover disease following lung transplantation
16. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
17. Prevention of bone loss in cardiac transplant patients. A comparison of bishophosphonates and vitamin D
18. Osteoporosis and bone morbidity in cardiac transplant recipients
19. Prevention of bone loss after heart transplantation with antiresorptive therapy: A pilot study
20. Loss of vertebral bone density in heart transplant patients
21. Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study
22. Prevalence of risk factors for osteopenia in dialysis patients
23. Changes in bone mass early after kidney transplantation
24. Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation
25. A prospective study of bone loss and turnover after allogene bone marrow transplantation: Effect of calcium supplementation with or without calcitonin
26. Bone densitometry and histomorphometry in patients with hairy cell leukaemia
27. Biologic and therapeutic determinants of bone mineral density in multiple myeloma
28. Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy
29. Absorption, hydroxylation and excretion of vitamin D3 in primary biliary cirrhosis
30. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis
31. Osteoporosis in chronic liver disease: Pathogenesis, risk factors, and management
32. Bone disease after liver transplantation
33. Loss of regional bone mineral density in the first 12 months following renal transplantation
34. Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients
35. Diabetic bone disease
36. Assessment of bone involvement in patients with multiple myeloma using bone densitometry
37. Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton
38. Cyclosporin A increases synthesis of 1,25 dihydroxyvitamin D 3 in the rat and mouse
39. Cyclosporin induced alteration in the hypothalamic hypophysial gonadal axis in transplant patients
40. Nephrotoxicity of immunosuppressive drugs
41. Long-term bone loss after renal transplantation: Comparison of immunosuppressive regimens
42. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: A prospective study
43. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation
44. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo
45. Practical considerations in the use of tacrolimus for allogenic marrow transplantation
46. Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression
47. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats
48. Rapamycin: A bone sparing immunosuppressant?
49. Osteoporotic fractures secondary to methotrexate therapy of acute leukaemia in remission
50. The effect of low dose methotrexate on bone metabolism and histomorphometry in rats
51. Bone mineral density in patients with Crohn's disease during long-term treatment with azathioprine
52. Mechanisms of bone loss following allogenic and autologous hematopoietic stem cell transplantation
53. Magnesium deficiency and bone loss after cardiac transplantation
54. Mechanism of bone loss after liver transplantation: A histomorphometric analysis
55. Adynamic bone lesion in renal transplant recipients with normal renal function
56. Bone loss in long-term renal transplantation: Histopathology and densitometry analysis
57. Cross-sectional analysis of renal transplantation osteoporosis
58. Steroid withdrawal is safe and beneficial in stable cyclosporin-treated liver transplant patients
59. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: A randomised, double blind study in kidney transplant patients
60. Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate
61. Calcitonin, etidronate and calcidiol treatment in bone loss after cardiac transplantation
62. Progression of steroid-associated osteoporosis after heart transplantation
63. A prospective study of bone loss and turnover after cardiac transplantation: Effect of calcium supplementation with or without calcitonin
64. Pamidronate therapy as prevention of bone loss following renal transplantation